It's a sensible solution to the issue, from a distance. Then there are realities like this: "Today, medical-journal editors estimate that 95 percent of the aca

It's a sensible solution to the issue, from a distance. Then there are realities like this: "Today, medical-journal editors estimate that 95 percent of the academic-medicine specialists who assess patented treatments have financial relationships with pharmaceutical companies, and even the prestigious NEJM [New England Journal of Medicine] gave up its search for objective reviewers in June 1992, announcing that it could find no reviewers that did not accept industry funds. Source: https://theamericanscholar.org/flacking-for-big-pharma/#.VOD_LsbzdTN https://theamericanscholar.org/flacking-for-big-pharma/#.VOD... [2011]